Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents

dc.contributor.authorAyoub, Abeer J.
dc.contributor.authorEl-Achkar, Ghewa A.
dc.contributor.authorGhayad, Sandra E.
dc.contributor.authorHariss, Layal
dc.contributor.authorHaidar, Razan H.
dc.contributor.authorAntar, Leen M.
dc.contributor.authorMallah, Zahraa I.
dc.contributor.authorBadran, Bassam M.
dc.contributor.authorGréé, Renè L.
dc.contributor.authorHachem, Ali
dc.contributor.authorHamade, Eva
dc.contributor.authorHabib, Aida A.
dc.contributor.departmentBiochemistry and Molecular Genetics
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:38:29Z
dc.date.available2025-01-24T11:38:29Z
dc.date.issued2023
dc.description.abstractBenzofuran and 2,3-dihydrobenzofuran scaffolds are heterocycles of high value in medicinal chemistry and drug synthesis. Targeting inflammation in cancer associated with chronic inflammation is a promising therapy. In the present study, we investigated the anti-inflammatory effects of fluorinated benzofuran and dihydrobenzofuran derivatives in macrophages and in the air pouch model of inflammation, as well as their anticancer effects in the human colorectal adenocarcinoma cell line HCT116. Six of the nine compounds suppressed lipopolysaccharide-stimulated inflammation by inhibiting the expression of cyclooxygenase-2 and nitric oxide synthase 2 and decreased the secretion of the tested inflammatory mediators. Their IC50 values ranged from 1.2 to 9.04 µM for interleukin-6; from 1.5 to 19.3 µM for Chemokine (C-C) Ligand 2; from 2.4 to 5.2 µM for nitric oxide; and from 1.1 to 20.5 µM for prostaglandin E2. Three novel synthesized benzofuran compounds significantly inhibited cyclooxygenase activity. Most of these compounds showed anti-inflammatory effects in the zymosan-induced air pouch model. Because inflammation may lead to tumorigenesis, we tested the effects of these compounds on the proliferation and apoptosis of HCT116. Two compounds with difluorine, bromine, and ester or carboxylic acid groups inhibited the proliferation by approximately 70%. Inhibition of the expression of the antiapoptotic protein Bcl-2 and concentration-dependent cleavage of PARP-1, as well as DNA fragmentation by approximately 80%, were described. Analysis of the structure–activity relationship suggested that the biological effects of benzofuran derivatives are enhanced in the presence of fluorine, bromine, hydroxyl, and/or carboxyl groups. In conclusion, the designed fluorinated benzofuran and dihydrobenzofuran derivatives are efficient anti-inflammatory agents, with a promising anticancer effect and a combinatory treatment in inflammation and tumorigenesis in cancer microenvironments. © 2023 by the authors.
dc.identifier.doihttps://doi.org/10.3390/ijms241210399
dc.identifier.eid2-s2.0-85163997159
dc.identifier.urihttp://hdl.handle.net/10938/29065
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.sourceScopus
dc.subjectBenzofuran
dc.subjectCyclooxygenase-2
dc.subjectHct116 cells
dc.subjectInflammation
dc.subjectMacrophage
dc.subjectProstaglandin e2
dc.subjectAcetylsalicylic acid
dc.subjectAntiinflammatory agent
dc.subjectAntineoplastic agent
dc.subjectArachidonic acid
dc.subjectBenzofuran derivative
dc.subjectBiological marker
dc.subjectBromine
dc.subjectCarboxyl group
dc.subjectColony stimulating factor 1
dc.subjectCxcl2 chemokine
dc.subjectCyclooxygenase 1 inhibitor
dc.subjectCyclooxygenase 2
dc.subjectCyclooxygenase 2 inhibitor
dc.subjectDihydrobenzofuran derivative
dc.subjectEster
dc.subjectFluorinated benzofuran
dc.subjectFluorine
dc.subjectHydroxyl group
dc.subjectIbuprofen
dc.subjectInducible nitric oxide synthase
dc.subjectInterleukin 1alpha
dc.subjectInterleukin 1beta
dc.subjectInterleukin 6
dc.subjectLipopolysaccharide
dc.subjectMessenger rna
dc.subjectMitogen activated protein kinase
dc.subjectMonocyte chemotactic protein 1
dc.subjectNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1
dc.subjectNitric oxide
dc.subjectProstaglandin e2
dc.subjectProtein bcl 2
dc.subjectProtein kinase b
dc.subjectUnclassified drug
dc.subjectZymosan
dc.subjectAir pouch
dc.subjectAkt signaling
dc.subjectAnimal cell
dc.subjectAnimal experiment
dc.subjectAnimal model
dc.subjectAnimal tissue
dc.subjectAntiinflammatory activity
dc.subjectAntineoplastic activity
dc.subjectAntiproliferative activity
dc.subjectApoptosis
dc.subjectApoptotic cell percentage
dc.subjectArticle
dc.subjectBiological activity
dc.subjectBone marrow derived macrophage
dc.subjectCarcinogenesis
dc.subjectCell proliferation
dc.subjectDna cleavage
dc.subjectDna fragmentation
dc.subjectDrug bioavailability
dc.subjectDrug design
dc.subjectDrug synthesis
dc.subjectEnzyme immunoassay
dc.subjectEnzyme linked immunosorbent assay
dc.subjectFemale
dc.subjectFlow cytometry
dc.subjectFluorination
dc.subjectGene expression
dc.subjectHct 116 cell line
dc.subjectHek293 cell line
dc.subjectHuman
dc.subjectHuman cell
dc.subjectIc50
dc.subjectIn vitro study
dc.subjectMale
dc.subjectMapk signaling
dc.subjectMolecular model
dc.subjectMonocyte
dc.subjectMouse
dc.subjectMrna expression level
dc.subjectNeutrophil
dc.subjectNonhuman
dc.subjectNuclear magnetic resonance
dc.subjectPermeability
dc.subjectProtein expression
dc.subjectReverse transcription polymerase chain reaction
dc.subjectSaponification
dc.subjectStructure activity relation
dc.subjectSynovium
dc.subjectThp-1 cell line
dc.subjectToxicity assay
dc.subjectTumor growth
dc.subjectTumor microenvironment
dc.subjectTunel assay
dc.subjectWst-1 assay
dc.titleFluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-690.pdf
Size:
3.79 MB
Format:
Adobe Portable Document Format